Anti-heart autoantibodies in familial dilated cardiomyopathy

Autoimmunity

Volumn 41, Issue 6, 2008, Pages 462-469

  Caforio, Alida L P ^a   Vinci, Annalisa ^a   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antibodies; Cardiomyopathy; Immunology; Myocarditis

Indexed keywords

ACTIN ANTIBODY; ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA 1 ADRENERGIC RECEPTOR; CARDIAC MYOSIN; HEART ANTIBODY; HLA ANTIGEN CLASS 2; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; MITOCHONDRION ANTIBODY; MYOSIN ANTIBODY; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA;

ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC VALUE; FAMILIAL DISEASE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HIGH RISK POPULATION; HUMAN; IMMUNOADSORPTION; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; MYOCARDITIS; NOMENCLATURE; NONHUMAN; PEDIGREE; PREDICTION; PROTEIN EXPRESSION; TREATMENT RESPONSE; VIRUS GENOME; VIRUS MYOCARDITIS; VIRUS PATHOGENESIS;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; HUMANS; MYOCARDITIS; MYOCARDIUM;

EID: 51849148032     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802031546     Document Type: Article

References (95)

1. Karkkainen, S. and Peuhkurinen, K. (2007) Genetics of dilated cardiomyopathy. Ann Med, 39, pp. 91-107.
2. MacLellan, RW and Lusis, AJ (2003) Dilated cardiomyopathy: Learning to live with yourself. Nat Med, 9, pp. 1455-1456.
3. Okazaki, T., Tanaka, Y. Nishio, R. et al. (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med, 9, pp. 1477-1483.
4. Eriksson, U., Ricci, R. Hunziker, L. et al. (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med, 9, pp. 1484-1490.
5. Richardson, P., McKenna, WJ Bristow, M. et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation, 93, pp. 841-842.
6. Caforio, ALP and McKenna, WJ (1996) Recognition and optimum treatment of myocarditis. Drugs, 52, pp. 515-525.
7. Maron, BJ, Towbin, JA Thiene, G. et al. (2006) Contemporary definitions and classification of cardiomyopathies. An American Heart Association Scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; quality of Care and Outcome research and Functional Genomics and Translational Biology Interdisciplinary Working Grou, 113, pp. 1807-1816.
8. Elliott, P., Andersson, B. Arbustini, E. et al. Classification of the cardiomyopathies: A position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2007
9. Pauschinger, M., Noutsias, M. Lassner, D. et al. (2006) Inflammation ECG Whom to biopsy in suspected myocarditis?. Clin Res Cardiol, 95, pp. 569-583.
10. Magnani, JW and Dec, WG (2006) Myocarditis. Current trends in diagnosis and treatment. Circulation, 113, pp. 876-890.
11. Caforio, ALP, Calabrese, F. Angelini, A. et al. (2007) A prospective study of biopsy-proven myocarditis: Prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J, 28, pp. 1326-1333.
12. Marin-Neto, JA, Cuhna-Neto, E., Maciel, BC and Simoes, MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation, 115, pp. 1109-1123.
13. Maekawa, Y., Ouzounian, M., Opavsky, A. and Liu, PP (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton and innate immunity. Circulation, 115, pp. 5-8.
14. Li, Y., Heuser, JS Cunningham, LC et al. (2006) Mimicry and antibody-mediated cell signalling in autoimmune myocarditis. J Immunol, 177, pp. 8234-8240.
15. Rose, NR (2000) Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat Med, 6, pp. 631-632.
16. Rose, NR and Bona, C. (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today, 14, pp. 426-428.
17. Aretz, HT, Billingham, ME Edwards, WE et al. (1985) Myocarditis: A histopathologic definition and classification. Am J Cardiol Pathol, 1, pp. 1-10.
18. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and shared controls. Nature, 447, pp. 661-683.
19. The International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med, 357, pp. 1-12.
20. Todd, JA, Walker, NM Cooper, JD et al. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet, 39, pp. 857-864.
21. Lowe, CE, Cooper, JD Brusko, T. et al. (2007) Large-scale genetic fine mapping and genotype-phenotype associations implicate a polymorphism in the IL2RA region in Type 1 diabetes. Nat Genet, 39, pp. 1074-1082.
22. Nejentsev, S., Howson, JMM Walker, NM et al. (2007) Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature
23. Lamparter, S., Pankuweit, S. and Maisch, B. (2007) Clinical and immunological characteristics in peripartum cardiomyopathy. Int J Cardiol, 118, pp. 14-20.
24. Portig, I., Wilke, A. Freyland, M. et al. (2006) Familial inflammatory dilated cardiomyopathy. Eur J Heart Fail, 8, pp. 816-825.
25. Mestroni, L., Rocco, C. Gregori, D. et al. (1999) Familial dilated cardiomyopathy:eVidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol, 34, pp. 181-190.
26. Basso, C., Thiene, G. Corrado, D. et al. (1996) Arrhythmogenic right ventricular cardiomyopathy: Dysplasia, dystrophy or myocarditis?. Circulation, 94, pp. 983-991.
27. Frustaci, A., Verardo, R. Caldarulo, M. et al. (2007) Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration. Eur Heart J, 28, pp. 733-740.
28. Frustaci, A., Priori, SG Pieroni, M. et al. (2005) Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation, 112, pp. 3680-3687.
29. Cooper, LT, Baughman, KL Feldman, AM et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. Nov, 650:19, pp. 1914-1931.
30. Skouri, HN, Dec, W. Friedrich, MG et al. (2006) Noninvasive imaging in myocarditis. J Am Coll Cardiol, 114, pp. 1581-1590.
31. Mahrholdt, H., Wagner, A. Deluigi, CC et al. (2006) Presentations, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation, 114, pp. 1581-1590.
32. Caforio, ALP, Stewart, JT Bonifacio, E. et al. (1990) Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity?. J Autoimmun, 3, pp. 187-200.
33. Mahon, NG, Madden, B. Caforio, ALP et al. (2002) Immunohistochemical evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol, 39, pp. 455-462.
34. Wojnicz, R., Nowalany-Kozielska, E. Wojciechowska, C. et al. (2001) Randomized, placebo controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation, 104, pp. 39-45.
35. Mahon, NG, Murphy, RT, MacRae, C., Caforio, ALP, Elliott, PM and McKenna, WJ (2005) Echocardiographic evaluation in asymptomatic relatives of dilated cardiomyopathy patients reveals preclinical disease. Ann Intern Med, 143, pp. 108-115.
36. Caforio, ALP, Keeling, PJ Zachara, E. et al. (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet, 344, pp. 773-777.
37. Caforio, ALP, Mahon, NG Baig, KM et al. (2007) Prospective familial assessment in dilated cardiomyopathy. Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation, 115, pp. 76-83.
38. Anderson, JL, Carlquist, JF Lutz, JR et al. (1984) HLA A, B, and DR typing in idiopathic dilated cardiomyopathy: A search for immune response factors. Am J Cardiol, 53, pp. 1326-1330.
39. Fletcher, GF and Wenger, NK (1968) Autoimmune studies in patients with primary myocardial disease. Circulation, 37, pp. 1032-1035.
40. Camp, FT, Hess, EV Conway, G. et al. (1969) Immunologic findings in idiopathic cardiomyopathy. Am Heart J, 77, pp. 610-615.
41. Kirsner, AB, Hess, EV and Fowler, NO (1973) Immunologic findings in idiopathic cardiomyopathy: A prospective serial study. Am Heart Journal, 86, pp. 625-630.
42. Maisch, B., Deeg, P. Liebau, G. et al. (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol, 52, pp. 1071-1078.
43. Maisch, B., Deeg, P. Liebau, G. et al. (1983) Diagnostic relevance of humoral and cell-mediated immune reactions in patients with viral myocarditis. Clin Exp Immun, 48, pp. 533-545.
44. Neumann, DA, Burek, CL Baughman, KL et al. (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol, 16, pp. 839-846.
45. Caforio, ALP, Bonifacio, E. Stewart, JT et al. (1990) Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol, 15, pp. 1527-1534.
46. Caforio, ALP, Wagner, R. Gill, JS et al. (1991) Organ-specific cardiac antibodies: Serological markers for systemic hypertension in autoimmune polyendocrinopathy. Lancet, 337, pp. 1111-1115.
47. Caforio, ALP, Goldman, JH Haven, AJ et al. (1997) Circulating cardiac autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. Eur Heart J, 18, pp. 270-275.
48. Caforio, ALP, Grazzini, M. Mann, JM et al. (1992) Identification of α and β cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation, 85, pp. 1734-1742.
49. Lauer, B., Schannwell, M. Kuhl, U. et al. (2000) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol, 35, pp. 11-18.
50. Latif, N., Baker, CS Dunn, MJ et al. (1993) Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol, 22, pp. 1378-1384.
51. Goldman, JH, Keeling, PJ Warraich, RS et al. (1995) Autoimmunity to α-myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J, 74, pp. 598-603.
52. Michels, VV, Moll, PP Rodeheffer, RJ et al. (1994) Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy. Mayo Clin Proc, 69, pp. 24-27.
53. Konstandoulakis, MM, Kroumbouzou, H., Tsiamis, E., Trikas, A. and Toutouzas, P. (1993) Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy. J Clin Lab Immunol, 40, pp. 61-67.
54. Warraich, RS, Dunn, MJ and Yacoub, MH (1999) Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: Proinflammatory antibodies in dilated cardiomyopathy patients. Biochem Biophys Res Commun, 259, pp. 255-261.
55. Portig, I., Pankuweit, S. and Maisch, B. (1997) Antibodies against stress proteins in sera of patients with dilated cardomyopathy. J Mol Cell Cardiol, 29, pp. 2245-2251.
56. Latif, N., Smith, J. Dunn, MJ et al. (1994) Complement-mediated cytotoxic activity of anti-heart antibodies present in the sera of patients with dilated cardiomyopathy. Autoimmunity, 19, pp. 99-104.
57. Staudt, A., Eichler, P. Trimpert, C. et al. (2007) Fcγ receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol, 49, pp. 1684-1692.
58. Baba, A., Yoshikawa, T. and Ogawa, S. (2002) Autoantibodies against sarcolemmal Na-K-ATPase: Possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy. J Am Coll Cardiol, 40, pp. 1153-1159.
59. Wolff, PG, Kuhl, U. and Schultheiss, HP (1989) Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J, 117, pp. 1303-1309.
60. Klein, R., Maisch, B. Kochsiek, K. et al. (1984) Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol, 58, pp. 283-292.
61. Otto, A., Stahle, I. Klein, R. et al. (1998) Anti-mitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD. Clin Exp Immunol, 111, pp. 541-547.
62. Schultheiss, HP and Bolte, HD (1985) Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol, 17, pp. 603-617.
63. Schultheiss, HP, Kuhl, U. Schwimmbeck, P. et al. (1990) Biomolecular changes in dilated cardiomyopathy. Advances in Cardiomyopathies, pp. 221-234. Springer Verlag, Berlin
64. Ansari, AA, Neckelmann, N. Villinger, F. et al. (1994) Epitope mapping of the branched chain α- ketoacid dehydrogenase dihydrolipoyl transacylase (BCKD-E2) protein that reacts with sera from patients with idiopathic dilated cardiomyopathy. J Immunol, 153, pp. 4754-4765.
65. Pohlner, K., Portig, I. Pankuweit, S. et al. (1997) Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol, 80, pp. 1040-1045.
66. Schultheiss, HP, Ulrich, G. Janda, I. et al. (1988) Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med, 168, pp. 2105-2119.
67. Wallukat, G., Morwinski, M. Kowal, K. et al. (1991) Antibodies against the β-adrenergic receptor in human myocarditis and dilated cardiomyopathy: β-Adrenergic agonism without desensitization. Eur Heart J, 12, pp. 178-181.
68. Limas, CJ Limas C. β-Receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J, 12, pp. 175-177.
69. 1-adrenoceptor with positive chronotropic effect. Circulation, 89, pp. 2760-2767.
70. Jahns, R., Boivin, V. Siegmund, C. et al. (1999) Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation, 99, pp. 649-654.
71. Jahns, R., Boivin, V. Krapf, T. et al. (2000) Modulation of β1-adrenoceptor activity by domain-specific antibodies and heart-failure associated autoantibodies. J Am Coll Cardiol, 36, pp. 1280-1287.
72. Fu, LX, Magnusson, Y. Bergh, CH et al. (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest, 91, pp. 1964-1968.
73. Marriott, JB, Goldman, JH, Keeling, PJ, Baig, MK, Dalgleish, AG and McKenna, WJ (1996) Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart, 75, pp. 287-290.
74. Kuan, AP, Zuckier, L. Liao, L. et al. (2000) Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naive mice. Circ Res, 86, pp. 281-285.
75. Neu, N., Rose, NR Beisel, KW et al. (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol, 139, pp. 3630-3636.
76. Smith, SC and Allen, PM (1991) Myosin-induced myocarditis is a T cell-mediated disease. J Immunol, 147, pp. 2141-2147.
77. Elliott, JF, Liu, J. Yuan, ZN et al. (2003) Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. PNAS, 100, pp. 13447-13452.
78. Taylor, JA, Havari, E. McInerney, MF et al. (2004) A spontaneous model for autoimmune myocarditis using the human MHC HLA-DQ8. J Immunol, 172, pp. 2651-2658.
79. Hayward, SL, Lopez-Bautista, N. Suzuki, K. et al. (2006) CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic Iab knockout nonobese diabetic mice. J Immunol, 176, pp. 7715-7725.
80. Taneja, V., Behrens, M. Cooper, LT et al. (2007) Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice. J Mol Cell Cardiol, 42, pp. 1054-1064.
81. Guler, ML, Ligons, DL Wang, Y. et al. (2005) Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol, 174, pp. 2167-2173.
82. Ono, M., Shimizu, J., Miyachi, Y. and Sakaguchi, S. (2006) Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family related protein high, Foxp3-expressing CD25+ and CD25-regulatory T cells. J Immunol, 176, pp. 4748-4756.
83. Jane-wit, D., Altuntas, CZ Johnson, JM et al. (2007) β1-Adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation, 116, pp. 399-410.
84. Mao, W., Fukuoka, S. Iwai, C. et al. (2007) Cardiomyocyte apoptosis in autoimmune cardiomyopathy:mEdiated via endoplasmic reticulum stress and exaggerated by noepinephrine. Am J Physiol Heart Circ Physiol, 293, pp. H1636-H1645.
85. Nishimura, H., Okazaki, T. Tanaka, Y. et al. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science, 291, pp. 319-322.
86. Caforio, ALP, Tona, F. Bottaro, S. et al. (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity, 41:1, pp. 35-45.
87. Mrena, S., Savola, K. Kulmala, P. et al. (2003) Genetic modification of risk assessment based on staging of preclinical Type 1 diabetes in siblings of affected children. J Clin Endocrinol Metab, 88, pp. 2682-2689.
88. Warraich, RS, Griffiths, E. Falconar, A. et al. (2006) Human cardiac myosin autoantibodies impair myocyte contractility: A cause-and-effect relationship. FASEB J, 20, pp. 651-660.
89. Mobini, R., Staudt, A. Felix, SB et al. (2003) Hemodynamic improvement and removal of autoantibodies against the β1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun, 20, pp. 345-350.
90. Urayama, O., Shutt, H. and Sweadner, J. (1989) Identification of three isozyme proteins of the catalytic subunit of the Na,K-ATPase in rat brain. J Biol Chem, 264, pp. 8271-8280.
91. Jahns, R., Boivin, V. Hein, L. et al. (2004) Direct evidence for a β1-adrenergic receptor directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest, 113, pp. 1419-1429.
92. Nikolaev, VO, Boivin, V. Stork, S. et al. (2007) A novel fluorescence method for the rapid detection of functional β1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol, 50, pp. 423-431.
93. Jahns, R., Boivin, V. Lohse, MJ et al. (2006) β1-Adrenergic receptor function, autoimmunity and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med, 16, pp. 20-24.
94. Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G. and Maseri, A. (2003) Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation, 107, pp. 857-863.
95. Ashrafian, H. and Watkins, H. (2007) Reviews of translational medicine and genomics in cardiovascular disease: New disease taxonomy and therapeutic implications. Cardiomyopathies therapeutics based on molecular phenotype. J Am Coll Cardiol, 49, pp. 1251-1264.